Trial intelligence / Profile preview

Evaluation of hydroxychloroquine for COVID-19 prophylaxis

IRCT20130917014693N10Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Apr 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of hydroxychloroquine in coronavirus pneumonia, sponsored by Shahid Beheshti University of Medical Sciences. Started Apr 2020; status: completed.

02

Drugs

hydroxychloroquine
03

Conditions

coronavirus pneumonia

Beyond the preview

Go deeper on IRCT20130917014693N10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20130917014693N10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call